Egetis Therapeutics AB (publ) Cash Flow Conversion Efficiency

Latest as of March 2026: -0.259x

Egetis Therapeutics AB (publ) cash flow conversion efficiency. Based on the latest financial reports, Egetis Therapeutics AB (publ) (EGTX) has a cash flow conversion efficiency ratio of -0.259x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-64.30 Million ≈ $-6.92 Million USD) by net assets (Skr248.70 Million ≈ $26.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Egetis Therapeutics AB (publ) (2010–2025)

Cash flow conversion efficiency of Egetis Therapeutics AB (publ) from 2010 to 2025. This chart illustrates how Egetis Therapeutics AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View EGTX share price today for real-time trading data and today's change.

Egetis Therapeutics AB (publ) Cash Flow Conversion Ratio Explained

Egetis Therapeutics AB (publ) cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Egetis Therapeutics AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Egetis Therapeutics AB (publ) ranked by their cash flow conversion efficiency. Also see Egetis Therapeutics AB (publ) stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Nagarro SE XETRA:NA9	0.166x
Zaptec AS OL:ZAP	0.579x
Sinosun Tech SHE:300333	-0.011x
Qualipoly Chemical Corp TW:4722	-0.027x
Fujian Rongji Software Co Ltd SHE:002474	-0.005x
HeNan Splendor Science & Technology Co Ltd SHE:002296	0.019x
Pony Testing International Group Co SHE:300887	0.041x
Martinrea International Inc. TO:MRE	0.075x

Annual Cash Flow Conversion Efficiency for Egetis Therapeutics AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Egetis Therapeutics AB (publ) from 2010 to 2025. Review EGTX cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr338.70 Million ≈ $36.45 Million	Skr-267.10 Million ≈ $-28.74 Million	-0.789x	-70.56%
2024-12-31	Skr492.90 Million ≈ $53.04 Million	Skr-227.90 Million ≈ $-24.53 Million	-0.462x	+9.39%
2023-12-31	Skr545.60 Million ≈ $58.72 Million	Skr-278.40 Million ≈ $-29.96 Million	-0.510x	-48.87%
2022-12-31	Skr506.20 Million ≈ $54.48 Million	Skr-173.50 Million ≈ $-18.67 Million	-0.343x	-38.84%
2021-12-31	Skr527.04 Million ≈ $56.72 Million	Skr-130.11 Million ≈ $-14.00 Million	-0.247x	-15.45%
2020-12-31	Skr629.63 Million ≈ $67.76 Million	Skr-134.64 Million ≈ $-14.49 Million	-0.214x	+16.41%
2019-12-31	Skr244.88 Million ≈ $26.35 Million	Skr-62.64 Million ≈ $-6.74 Million	-0.256x	+30.13%
2018-12-31	Skr219.36 Million ≈ $23.61 Million	Skr-80.31 Million ≈ $-8.64 Million	-0.366x	-28.47%
2017-12-31	Skr303.71 Million ≈ $32.68 Million	Skr-86.55 Million ≈ $-9.31 Million	-0.285x	-207.40%
2016-12-31	Skr389.56 Million ≈ $41.92 Million	Skr-36.12 Million ≈ $-3.89 Million	-0.093x	+91.29%
2015-12-31	Skr48.03 Million ≈ $5.17 Million	Skr-51.15 Million ≈ $-5.50 Million	-1.065x	-133.30%
2014-12-31	Skr90.66 Million ≈ $9.76 Million	Skr-41.38 Million ≈ $-4.45 Million	-0.456x	+23.63%
2013-12-31	Skr46.95 Million ≈ $5.05 Million	Skr-28.07 Million ≈ $-3.02 Million	-0.598x	-0.89%
2012-12-31	Skr53.94 Million ≈ $5.80 Million	Skr-31.96 Million ≈ $-3.44 Million	-0.592x	-260.23%
2011-12-31	Skr87.53 Million ≈ $9.42 Million	Skr-14.40 Million ≈ $-1.55 Million	-0.164x	+57.69%
2010-12-31	Skr6.99 Million ≈ $752.22K	Skr-2.72 Million ≈ $-292.41K	-0.389x	--

About Egetis Therapeutics AB (publ)

ST:EGTX Sweden Biotechnology

Market Cap

$499.86 Million

Skr4.64 Billion SEK

Market Cap Rank

#11926 Global

#196 in Sweden

Share Price

Skr9.99

Change (1 day)

+0.50%

52-Week Range

Skr4.32 - Skr10.34

All Time High

Skr57.90